Enterprise Value
-173.2M
Cash
314.1M
Avg Qtr Burn
-11.59M
Short % of Float
3.72%
Insider Ownership
13.63%
Institutional Own.
87.85%
Qtr Updated
06/30/23
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|